These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25326098)

  • 1. Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease.
    Theuns J; Verstraeten A; Sleegers K; Wauters E; Gijselinck I; Smolders S; Crosiers D; Corsmit E; Elinck E; Sharma M; Krüger R; Lesage S; Brice A; Chung SJ; Kim MJ; Kim YJ; Ross OA; Wszolek ZK; Rogaeva E; Xi Z; Lang AE; Klein C; Weissbach A; Mellick GD; Silburn PA; Hadjigeorgiou GM; Dardiotis E; Hattori N; Ogaki K; Tan EK; Zhao Y; Aasly J; Valente EM; Petrucci S; Annesi G; Quattrone A; Ferrarese C; Brighina L; Deutschländer A; Puschmann A; Nilsson C; Garraux G; LeDoux MS; Pfeiffer RF; Boczarska-Jedynak M; Opala G; Maraganore DM; Engelborghs S; De Deyn PP; Cras P; Cruts M; Van Broeckhoven C;
    Neurology; 2014 Nov; 83(21):1906-13. PubMed ID: 25326098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between repeat number in C9orf72 and phenotypic variability in Turkish patients with frontotemporal lobar degeneration.
    Erzurumluoglu E; Cilingir O; Ozbabalik Adapinar BD; Bilgic B; Kocagil S; Ozen H; Durak Aras B; Yenilmez C; Artan S
    Neurobiol Aging; 2019 Apr; 76():216.e1-216.e7. PubMed ID: 30685122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson disease is not associated with C9ORF72 repeat expansions.
    Harms MB; Neumann D; Benitez BA; Cooper B; Carrell D; Racette BA; Perlmutter JS; Goate A; Cruchaga C
    Neurobiol Aging; 2013 May; 34(5):1519.e1-2. PubMed ID: 23116878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of C9orf72 repeat expansions in Parkinson's disease.
    Daoud H; Noreau A; Rochefort D; Paquin-Lanthier G; Gauthier MT; Provencher P; Pourcher E; Dupré N; Chouinard S; Jodoin N; Soland V; Fon EA; Dion PA; Rouleau GA
    Neurobiol Aging; 2013 Jun; 34(6):1710.e7-9. PubMed ID: 23273600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of the association between
    Jin P; Li Y; Li Y
    J Neurogenet; 2024 Mar; 38(1):1-8. PubMed ID: 38767957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency of the C9orf72 expansion in a Brazilian population.
    Cintra VP; Bonadia LC; Andrade HMT; de Albuquerque M; Eusébio MF; de Oliveira DS; Claudino R; Gonçalves MVM; Teixeira AL; de Godoy Rousseff Prado L; de Souza LC; Dourado MET; Oliveira ASB; Tumas V; França MC; Marques W
    Neurobiol Aging; 2018 Jun; 66():179.e1-179.e4. PubMed ID: 29449030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients.
    Xi Z; Zhang M; Bruni AC; Maletta RG; Colao R; Fratta P; Polke JM; Sweeney MG; Mudanohwo E; Nacmias B; Sorbi S; Tartaglia MC; Rainero I; Rubino E; Pinessi L; Galimberti D; Surace EI; McGoldrick P; McKeever P; Moreno D; Sato C; Liang Y; Keith J; Zinman L; Robertson J; Rogaeva E
    Acta Neuropathol; 2015 May; 129(5):715-27. PubMed ID: 25716178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C9orf72 repeat expansions are a rare genetic cause of parkinsonism.
    Lesage S; Le Ber I; Condroyer C; Broussolle E; Gabelle A; Thobois S; Pasquier F; Mondon K; Dion PA; Rochefort D; Rouleau GA; Dürr A; Brice A;
    Brain; 2013 Feb; 136(Pt 2):385-91. PubMed ID: 23413259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment.
    Cacace R; Van Cauwenberghe C; Bettens K; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Bäumer V; Dillen L; Mattheijssens M; Peeters K; Cruts M; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Sleegers K
    Neurobiol Aging; 2013 Jun; 34(6):1712.e1-7. PubMed ID: 23352322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of C9orf72 in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Argentina.
    Itzcovich T; Xi Z; Martinetto H; Chrem-Méndez P; Russo MJ; de Ambrosi B; Uchitel OD; Nogués M; Silva E; Rojas G; Bagnatti P; Amengual A; Campos J; Rogaeva E; St George-Hyslop P; Allegri R; Sevlever G; Surace EI
    Neurobiol Aging; 2016 Apr; 40():192.e13-192.e15. PubMed ID: 26925510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large C9orf72 repeat expansions are not a common cause of Parkinson's disease.
    Majounie E; Abramzon Y; Renton AE; Keller MF; Traynor BJ; Singleton AB
    Neurobiol Aging; 2012 Oct; 33(10):2527.e1-2. PubMed ID: 22721568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of
    Sokratous M; Lucia S; Bourinaris T; Marogianni C; Arnaoutoglou M; Patrikiou E; Ralli S; Markou A; Dardiotis E; Houlden H; Hadjigeorgiou GM; Xiromerisiou G
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Aug; 21(5-6):470-472. PubMed ID: 32338076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association study of frontotemporal dementia identifies a C9ORF72 haplotype with a median of 12-G4C2 repeats that predisposes to pathological repeat expansions.
    Reus LM; Jansen IE; Mol MO; van Ruissen F; van Rooij J; van Schoor NM; Tesi N; Reinders MJT; Huisman MA; Holstege H; Visser PJ; de Boer SCM; Hulsman M; Ahmad S; Amin N; Uitterlinden AG; Ikram A; van Duijn CM; Seelaar H; Ramakers IHGB; Verhey FRJ; van der Lugt A; Claassen JAHR; Jan Biessels G; De Deyn PP; Scheltens P; van der Flier WM; van Swieten JC; Pijnenburg YAL; van der Lee SJ
    Transl Psychiatry; 2021 Sep; 11(1):451. PubMed ID: 34475377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of DNA G-quadruplex species forming from C9ORF72 G4C2-expanded repeats associated with amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Šket P; Pohleven J; Kovanda A; Štalekar M; Župunski V; Zalar M; Plavec J; Rogelj B
    Neurobiol Aging; 2015 Feb; 36(2):1091-6. PubMed ID: 25442110
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Kobo H; Goldstein O; Gana-Weisz M; Bar-Shira A; Gurevich T; Thaler A; Mirelman A; Giladi N; Orr-Urtreger A
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No GGGGCC-hexanucleotide repeat expansion in C9ORF72 in parkinsonism patients in Sweden.
    Akimoto C; Forsgren L; Linder J; Birve A; Backlund I; Andersson J; Nilsson AC; Alstermark H; Andersen PM
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Jan; 14(1):26-9. PubMed ID: 22985429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.
    Narain P; Gomes J; Bhatia R; Singh I; Vivekanandan P
    Neurobiol Aging; 2017 Aug; 56():211.e9-211.e14. PubMed ID: 28527524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.
    Gijselinck I; Van Mossevelde S; van der Zee J; Sieben A; Engelborghs S; De Bleecker J; Ivanoiu A; Deryck O; Edbauer D; Zhang M; Heeman B; Bäumer V; Van den Broeck M; Mattheijssens M; Peeters K; Rogaeva E; De Jonghe P; Cras P; Martin JJ; de Deyn PP; Cruts M; Van Broeckhoven C
    Mol Psychiatry; 2016 Aug; 21(8):1112-24. PubMed ID: 26481318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.